Adenosine derivatives
US6492348B1 · kind B1 · utility
11Cited by
4References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 6, 2001 |
| Grant date | Dec 10, 2002 |
| Priority date | — |
| Expiry date | Mar 6, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula (I) which is an agonist at the adenosine Al receptor, wherein Y, Z, and W represent heteroatoms, and salts and solvates thereof, in particular, physiologically acceptable solvates and salts thereof for use in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.